Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.

Authors:
Patrick O Wagers Kristin M Tiemann Kerri L Shelton William G Kofron Matthew J Panzner Karen L Wooley Wiley J Youngs David A Hunstad

Antimicrob Agents Chemother 2015 Sep 29;59(9):5494-502. Epub 2015 Jun 29.

Department of Pediatrics, Washington University, St. Louis, Missouri, USA Department of Molecular Microbiology, Washington University, St. Louis, Missouri, USA

We present a novel family of small-molecule urinary bladder exfoliants that are expected to be of great value in preclinical studies of urologic conditions and have improved potential for translation compared with prior agents. There is broad urologic interest in the therapeutic potential of such exfoliating agents. The primary agent used in preclinical models, the cationic peptide protamine sulfate (PS), has limited translational potential due to concerns including systemic adverse reactions and bladder tissue injury. Intravesical application of a safe, systemically nontoxic exfoliant would have potential utility in the eradication of Escherichia coli and other uropathogens that reside in the bladder epithelium following cystitis, as well as in chronic bladder pain and bladder cancer. Here, we introduce a family of imidazolium salts with potent and focused exfoliating activity on the bladder epithelium. Synthesis and purification were straightforward and scalable, and the compounds exhibited prolonged stability in lyophilized form. Most members of the compound family were cytotoxic to cultured uroepithelial cells, with >10-fold differences in potency across the series. Upon topical (intravesical) administration of selected compounds to the murine bladder, complete epithelial exfoliation was achieved with physiologically relevant imidazolium concentrations and brief contact times. The exfoliative activity of these compounds was markedly improved in comparison to PS, as assessed by microscopy, immunofluorescence, and immunoblotting for uroplakins. Bladder uroepithelium regenerated within days to yield a histologically normal appearance, and no toxicity was observed. Finally, the chemical scaffold offers an opportunity for inclusion of antimicrobials or conjugation with chemotherapeutic or other moieties.

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00881-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538537PMC
September 2015

Publication Analysis

Top Keywords

bladder
9
bladder exfoliants
8
small-molecule urinary
8
urinary bladder
8
bladder epithelium
8
imidazolium salts
8
pain bladder
4
microscopy immunofluorescence
4
bladder cancer
4
bladder pain
4
chronic bladder
4
cancer introduce
4
well chronic
4
immunofluorescence immunoblotting
4
cystitis well
4
salts potent
4
exfoliating activity
4
activity bladder
4
comparison assessed
4
epithelium synthesis
4

Keyword Occurance

Similar Publications

Connection between traumatic frontal intracerebral hemorrhage and lower urinary tract symptoms.

Authors:
R Akhavan-Sigari L Trakolis B Amend S Herlan

Eur Rev Med Pharmacol Sci 2021 Apr;25(7):2994-3001

Department of Neurosurgery, University Medical Center Tuebingen, Germany.

Objective: There have been no previous studies of urinary symptoms in patients with traumatic frontal intracerebral hemorrhage. The purpose of this work was to provide first insights into the potential role of traumatic frontal intracerebral hemorrhage in the development of urinary symptoms. This condition is known to cause compression in and around the prefrontal cortex, and we wanted to examine its effect on the micturition center. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy.

Authors:
Reza Boostani Mina Khodabandeh Seyyed Abdolrahim Rezaee Houshang Rafatpanah Sanaz Ahmadi Ghezeldasht Zohreh Vahidi Zahra Baghestani

J Neurovirol 2021 Apr 20. Epub 2021 Apr 20.

Department of Neurology, Faculty of Medicine, Qaem Hospital, Mashhad University of Medical Sciences, Ahmadabad Avenue, 91766-99199, Mashhad, Iran.

Human T-cell lymphotropic virus type 1 (HTLV-1) infection can cause HTLV-I-associated myelopathy (HAM). In this study, we evaluated the levels of serum iron, ferritin, copper, and ceruloplasmin, and their correlations with HTLV-1 proviral load (PVL) and standard indices of HAM severity. In total, 114 subjects were recruited in this cross sectional study in Qaem Hospital, Mashhad, Iran between 2017 and 2018, including 36 HAM and 32 asymptomatic cases (ACs) and 46 healthy people (HSs). Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review.

Authors:
Lynsey Lakin Bryan E Davis Cherie C Binns Keisha M Currie Mary R Rensel

Neurol Ther 2021 Apr 20. Epub 2021 Apr 20.

Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.

Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system, leading to neurodegeneration and manifesting as a variety of symptoms. These can include "invisible" symptoms, not externally evident to others, such as fatigue, mood disorders, cognitive impairments, pain, bladder/bowel dysfunction, sexual dysfunction, and vision changes. Invisible symptoms are highly prevalent in people living with MS, with multifactorial etiology and potential to impact the disease course. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

The potential role of miR-124-3p in tumorigenesis and other related diseases.

Authors:
Qian Li Shuqing Liu Jinsong Yan Ming-Zhong Sun Frederick T Greenaway

Mol Biol Rep 2021 Apr 20. Epub 2021 Apr 20.

Carlson School of Chemistry and Biochemistry, Clark University, Worcester, MA, 01610, USA.

MicroRNAs (miRNAs) are a class of single-stranded noncoding and endogenous RNA molecules with a length of 18-25 nucleotides. Previous work has shown that miR-124-3p leads to malignant progression of cancer including cell apoptosis, migration, invasion, drug resistance, and also recovers neural function, affects adipogenic differentiation, facilitates wound healing through control of various target genes. miR-124-3p has been mainly previously characterized as a tumor suppressor regulating tumorigenesis and progression in several cancers, such as hepatocellular carcinoma (HCC), gastric cancer (GC), bladder cancer, ovarian cancer (OC), and leukemia, as a tumor promotor in breast cancer (BC), and it has been also widely studied in a variety of neurological diseases, like Parkinson's disease (PD), dementia and Alzheimer's disease (AD), and cardiovascular diseases, ulcerative colitis (UC), acute respiratory distress syndrome (ARDS). Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Primary Takotsubo Syndrome as a Complication of Bladder Cancer Treatment in a 62-Year-Old Woman.

Authors:
Małgorzata Zalewska-Adamiec Paulina Klonowska Jolanta Małyszko Łukasz Kuźma Hanna Bachorzewska-Gajewska Sławomir Dobrzycki

Am J Case Rep 2021 Apr 20;22:e930090. Epub 2021 Apr 20.

Department of Invasive Cardiology, Medical University in Białystok, Białystok, Poland.

BACKGROUND The main causes for takotsubo syndrome (TS) in oncological patients are stress related to cancer diagnosis and treatment, pain in the course of the disease, treatment complications, and paraneoplastic syndromes. CASE REPORT An obese 62-year-old female patient, with a 3-day history of chest pain, was admitted to the hospital with a suspected acute coronary event. She had been diagnosed with high-grade bladder cancer 6 months before. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap